These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 30341011)

  • 1. Loss of Shp2 Rescues BDNF/TrkB Signaling and Contributes to Improved Retinal Ganglion Cell Neuroprotection.
    Chitranshi N; Dheer Y; Mirzaei M; Wu Y; Salekdeh GH; Abbasi M; Gupta V; Vander Wall R; You Y; Graham SL; Gupta V
    Mol Ther; 2019 Feb; 27(2):424-441. PubMed ID: 30341011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroprotection of retinal ganglion cells by a novel gene therapy construct that achieves sustained enhancement of brain-derived neurotrophic factor/tropomyosin-related kinase receptor-B signaling.
    Osborne A; Khatib TZ; Songra L; Barber AC; Hall K; Kong GYX; Widdowson PS; Martin KR
    Cell Death Dis; 2018 Sep; 9(10):1007. PubMed ID: 30258047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Shp-2 regulates the TrkB receptor activity in the retinal ganglion cells under glaucomatous stress.
    Gupta VK; You Y; Klistorner A; Graham SL
    Biochim Biophys Acta; 2012 Nov; 1822(11):1643-9. PubMed ID: 22878065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroprotection of Retinal Ganglion Cells with AAV2-BDNF Pretreatment Restoring Normal TrkB Receptor Protein Levels in Glaucoma.
    Wójcik-Gryciuk A; Gajewska-Woźniak O; Kordecka K; Boguszewski PM; Waleszczyk W; Skup M
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32872441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inner retinal injury in experimental glaucoma is prevented upon AAV mediated Shp2 silencing in a caveolin dependent manner.
    Abbasi M; Gupta VK; Chitranshi N; Gupta V; Ranjbaran R; Rajput R; Pushpitha K; Kb D; You Y; Salekdeh GH; Parton RG; Mirzaei M; Graham SL
    Theranostics; 2021; 11(13):6154-6172. PubMed ID: 33995651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tackling Glaucoma from within the Brain: An Unfortunate Interplay of BDNF and TrkB.
    Dekeyster E; Geeraerts E; Buyens T; Van den Haute C; Baekelandt V; De Groef L; Salinas-Navarro M; Moons L
    PLoS One; 2015; 10(11):e0142067. PubMed ID: 26560713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurotrophin receptor TrkB activation is not required for the postnatal survival of retinal ganglion cells in vivo.
    Rohrer B; LaVail MM; Jones KR; Reichardt LF
    Exp Neurol; 2001 Nov; 172(1):81-91. PubMed ID: 11681842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BDNF impairment is associated with age-related changes in the inner retina and exacerbates experimental glaucoma.
    Gupta V; You Y; Li J; Gupta V; Golzan M; Klistorner A; van den Buuse M; Graham S
    Biochim Biophys Acta; 2014 Sep; 1842(9):1567-78. PubMed ID: 24942931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enriched environment during adolescence changes brain-derived neurotrophic factor and TrkB levels in the rat visual system but does not offer neuroprotection to retinal ganglion cells following axotomy.
    Franklin TB; Murphy JA; Myers TL; Clarke DB; Currie RW
    Brain Res; 2006 Jun; 1095(1):1-11. PubMed ID: 16730677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Obstructed axonal transport of BDNF and its receptor TrkB in experimental glaucoma.
    Pease ME; McKinnon SJ; Quigley HA; Kerrigan-Baumrind LA; Zack DJ
    Invest Ophthalmol Vis Sci; 2000 Mar; 41(3):764-74. PubMed ID: 10711692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does elevated intraocular pressure reduce retinal TRKB-mediated survival signaling in experimental glaucoma?
    Guo Y; Johnson E; Cepurna W; Jia L; Dyck J; Morrison JC
    Exp Eye Res; 2009 Dec; 89(6):921-33. PubMed ID: 19682984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucocorticoid suppresses BDNF-stimulated MAPK/ERK pathway via inhibiting interaction of Shp2 with TrkB.
    Kumamaru E; Numakawa T; Adachi N; Kunugi H
    FEBS Lett; 2011 Oct; 585(20):3224-8. PubMed ID: 21946312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TrkB Receptor Agonist 7,8 Dihydroxyflavone is Protective Against the Inner Retinal Deficits Induced by Experimental Glaucoma.
    Gupta V; Chitranshi N; Gupta V; You Y; Rajput R; Paulo JA; Mirzaei M; van den Buuse M; Graham SL
    Neuroscience; 2022 May; 490():36-48. PubMed ID: 35217121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Caveolin-1 Ablation Imparts Partial Protection Against Inner Retinal Injury in Experimental Glaucoma and Reduces Apoptotic Activation.
    Abbasi M; Gupta VK; Chitranshi N; Gupta VB; Mirzaei M; Dheer Y; Garthwaite L; Zaw T; Parton RG; You Y; Graham SL
    Mol Neurobiol; 2020 Sep; 57(9):3759-3784. PubMed ID: 32578008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Valproate promotes survival of retinal ganglion cells in a rat model of optic nerve crush.
    Zhang ZZ; Gong YY; Shi YH; Zhang W; Qin XH; Wu XW
    Neuroscience; 2012 Nov; 224():282-93. PubMed ID: 22867974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retrograde axonal transport obstruction of brain-derived neurotrophic factor (BDNF) and its TrkB receptor in the retina and optic nerve of American Cocker Spaniel dogs with spontaneous glaucoma.
    Iwabe S; Moreno-Mendoza NA; Trigo-Tavera F; Crowder C; García-Sánchez GA
    Vet Ophthalmol; 2007; 10 Suppl 1():12-9. PubMed ID: 17973830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TrkB receptor signaling regulates developmental death dynamics, but not final number, of retinal ganglion cells.
    Pollock GS; Robichon R; Boyd KA; Kerkel KA; Kramer M; Lyles J; Ambalavanar R; Khan A; Kaplan DR; Williams RW; Frost DO
    J Neurosci; 2003 Nov; 23(31):10137-45. PubMed ID: 14602830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rat retinal ganglion cells co-express brain derived neurotrophic factor (BDNF) and its receptor TrkB.
    Vecino E; García-Crespo D; García M; Martinez-Millán L; Sharma SC; Carrascal E
    Vision Res; 2002 Jan; 42(2):151-7. PubMed ID: 11809469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An agonistic TrkB mAb causes sustained TrkB activation, delays RGC death, and protects the retinal structure in optic nerve axotomy and in glaucoma.
    Bai Y; Xu J; Brahimi F; Zhuo Y; Sarunic MV; Saragovi HU
    Invest Ophthalmol Vis Sci; 2010 Sep; 51(9):4722-31. PubMed ID: 20357199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The protein tyrosine phosphatase, Shp2, is required for the complete activation of the RAS/MAPK pathway by brain-derived neurotrophic factor.
    Easton JB; Royer AR; Middlemas DS
    J Neurochem; 2006 May; 97(3):834-45. PubMed ID: 16573649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.